Navigation Links
Dendreon Presents Data Correlating the Cumulative Potency of PROVENGE(R) to Overall Survival
Date:2/14/2008

o fight cancer. The Company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy product candidates designed to stimulate an immune response. Active cellular immunotherapy holds promise because it may provide patients with a meaningful clinical benefit, such as survival, combined with low toxicity. The Company has its headquarters in Seattle, Washington and is traded on the NASDAQ Global Market under the symbol DNDN. For more information about the Company and its programs, visit http://www.dendreon.com.

Except for historical information contained herein, this news release contains forward-looking statements that are subject to risks and uncertainties surrounding the efficacy of PROVENGE to treat men suffering from prostate cancer, risks and uncertainties surrounding the presentation of data to the FDA and approval of product applications by the FDA and risks and uncertainties inherent in the process of discovering, developing and commercializing drugs that are safe and effective for use as human therapeutics. Factors that may cause such differences include risks related to our limited operating history, risks associated with completing our clinical trials, the risk that the safety and/or efficacy results of existing clinical trials or from additional clinical trials for PROVENGE will not support approval for a biologics license, the risk that the FDA may interpret data differently than we do or require more data or a more rigorous analysis of data than expected, the risk that the FDA will not approve a product for which a biologics license has been applied, the risk that the results of a clinical trial for PROVENGE or other product may not be indicative of results obtained in a later clinical trial, risks that we may lack the financial resources and access to capital to fund required clinical trials or commercialization of PROVENGE, our dep
'/>"/>

SOURCE Dendreon Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Dendreon Completes Target Enrollment of 500 Patients in Phase 3 IMPACT Study of Provenge(R) For Advanced Prostate Cancer
3. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
4. EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
5. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
6. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
7. CEL-SCI Presents Data for CEL-1000 as a Vaccine Adjuvant with Recombinant Hepatitis B Virus Protein
8. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
9. Targanta Presents First Data Demonstrating In Vitro Activity and In Vivo Efficacy of Prodrugs in Osteomyelitis Models
10. Wyeth Presents Phase 3 Fracture Data for Bazedoxifene, an Investigational Therapy for Osteoporosis
11. Aegerion Pharmaceuticals, Inc. Presents Final Results of Phase II Clinical Trials for AEGR-733 at Drugs Affecting Lipid Metabolism (DALM) 2007 Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... 29, 2015  The annual customer satisfaction survey of ... EMR as #1 across all specialties. Every year, ... conducts a poll of EHR users and publishes an ... Praxis EMR topped 348 other systems, ... based criteria used by Black Book. In addition to ...
(Date:5/29/2015)... DIEGO and BOSTON , ... leader in instrument development, custom automation, and contract manufacturing, ... of the Nanopatch™ needle-free drug delivery technology, have been ... development of the Nanopatch Jet Coating Instrument , ... delivery research and product development.  The award was announced ...
(Date:5/29/2015)...  Haemonetics Corporation (NYSE: HAE ) announced today ... present at the JMP Securities Life Sciences Conference in ... rd , 2015 at 11:30am Eastern time.  ... via webcast at: http://wsw.com/webcast/jmp27/hae ... a global healthcare company dedicated to providing innovative blood ...
Breaking Medicine Technology:Praxis EMR Ranks #1 for Physician Satisfaction in Black Book's 2015 Survey of Solo and Small Practices 2Invetech And Vaxxas Named Recipients Of The 2015 Good Design Award For Development Of Nanopatch Jet Coating Instrument For Needle-Free Drug Delivery 2Invetech And Vaxxas Named Recipients Of The 2015 Good Design Award For Development Of Nanopatch Jet Coating Instrument For Needle-Free Drug Delivery 3
... June 23, 2011 ULURU Inc. (NYSE AMEX: ... Gilford Securities Incorporated ("Gilford") to serve as the Company,s financial ... banking services and is a full service national investment firm ... engagement includes assisting the Company to broaden its investor base ...
...   MacroGenics, Inc., a privately held biotechnology company that ... diseases, today announced that 1-year data from Protege, the ... 1 diabetes patients, will be presented at the American ... California on June 28, 2011 at 9:10 a.m. PDT. ...
Cached Medicine Technology:ULURU Inc. Announces the Engagement of Gilford Securities Incorporated to Serve as the Company's Financial Advisor 2MacroGenics Announces Presentation of Protege Phase 3 Clinical Data at ADA in San Diego on June 28 2
(Date:5/30/2015)... VA (PRWEB) May 30, 2015 ... Foundation interviewed Dr. Charles Simone and Dr. Evan ... during its ‘Meet the Mesothelioma Experts’ series. The ... focusing on mesothelioma centers of excellence. Drs. Simone ... executive director, Mary Hesdorffer, with whom they discussed ...
(Date:5/30/2015)... Nicole Blodgett, Vice President of Secura ... designation to further her expertise in the income ... insurance advisors, health care professionals, and financial planners ... associated with the risk and the cost with ... the latest accomplishment in Nicole's journey with Secura ...
(Date:5/30/2015)... San Luis Obispo, CA (PRWEB) May 30, 2015 ... Susan Polk announced today that she is offering a ... insurance. , The offer coincides with Disability Awareness ... Life Happens . Industry members across the United States ... as a time to raise awareness about the possibility ...
(Date:5/30/2015)... (PRWEB) May 30, 2015 A live ... of medical equipment from hospitals, surgery centers and other ... equipment will be sold including radiology, surgery, endoscopy, lab, ... auction will take place Tuesday, June 2nd starting at ... warehouse located at 5025 North Hiatus Rd., Sunrise, FL ...
(Date:5/29/2015)... 29, 2015 Based in St. Louis, Missouri ... shirts for a couple of months now and are ... release, which reads “I’m not misbehaving, I have Autism, please ... parent’s of an autistic child in order to start a ... Not only are they raising awareness through the autism awareness ...
Breaking Medicine News(10 mins):Health News:Interview with Mesothelioma Experts, Drs. Simone and Alley Now Available on Demand 2Health News:Secura Consultants Expands Disability Insurance Expertise 2Health News:San Luis Obispo Insurance Agent Susan Polk Offering Complementary Insurance Analysis In Honor Of Disability Awareness Month 2Health News:Centurion to Sell Surplus Medical Equipment in Online and On-site Auction 2Health News:La La Land Shirts Is Busy Spreading Autism Awareness with Complimentary Shipping on Their New Shirt 2
... to ... the Rules for Healthcare Payors, BURLINGTON, Mass., April ... benefit administration, business,intelligence and portal software products for healthcare ... investment commitment from,Psilos Group, a leading healthcare venture capital ...
... XR, Will Earn a 16 Percent Patient Share in the Bipolar ... ... Decision Resources, WALTHAM, Mass., April 22 Decision Resources, one of ... that a therapy that carries a lower risk of weight,gain than AstraZeneca,s ...
... Diversified Agency Services, a,division of Omnicom Group Inc. ... healthcare and pharmaceutical agencies Cline Davis Mann, Corbett and,Flashpoint ... at the 19th Annual,Manny Awards., Cline Davis Mann ... all,agencies with annual revenue of more than $50 million. ...
... MONICA, Calif., April 22 Aida,Pharmaceuticals, Inc. ... of an investor-focused corporate synopsis on its ... be downloaded as a,pdf document. The synopsis ... current product line, the drugs in its,development ...
... 22 WallSt.net,s 3-Minute,Press Show is a daily ... Shows air Monday through Friday on:, http://tv.wallst.net/3-min-press/3-min-press.php ... interviews with,public company executives on their company and ... provide viewers with insight into a company,s most,recent ...
... American College of Allergy,Asthma & Immunology (ACAAI) recently ... highlight the importance of improving care for those,who ... important,information for physicians and patients are available today ... who are,committed to driving the dialogue about unmet ...
Cached Medicine News:Health News:HealthEdge Receives $13 Million Investment Commitment to Fund Significant Growth 2Health News:A Drug That Carries a Lower Risk of Weight Gain Than AstraZeneca's Seroquel and Has Antimanic and Antidepressant Effects Would Earn a 30 Percent Patient Share in Bipolar Disorder Treatment 2Health News:Omnicom's Diversified Agency Services Healthcare Agencies Top Med Ad News' Manny Awards 2Health News:Aida Pharmaceuticals, Inc. Announces Availability of Downloadable Corporate Synopsis on its Website 2Health News:Featured Stocks on Today's Edition of WallSt.net's 3-Minute Press Show: CYRX, RHWI 2
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations....
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations....
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations....
This dissector offers dual-action jaws, which are long, tapered, and angled 30 to simplify even difficult laparoscopic dissection....
Medicine Products: